IART vs SMTI
IART: Integra LifeSciences is a medical technology company specializing in regenerative medicine, neurosurgery, and advanced surgical instrumentation. SMTI: Sanara MedTech develops surgical wound care and bone fusion implant solutions designed to improve clinical outcomes and reduce healthcare costs in the operating room.
Side-by-side fundamentals
| Metric | IART | SMTI | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $18.82 | $25.54 | |
| Market cap as of 2026-07-23 | $1.5B | $234M | |
| PEG as of 2026-07-23 | -0.00 | -0.03 | SMTI lower |
| Net margin as of 2026-07-23 | -30.1% | -38.6% | IART higher |
| Gross margin as of 2026-07-23 | +57.1% | +93.1% | SMTI higher |
| Operating margin as of 2026-07-23 | -28.4% | +8.1% | SMTI higher |
| ROE as of 2026-07-23 | -47.6% | -246.4% | IART higher |
| ROA as of 2026-07-23 | -13.7% | -43.0% | IART higher |
| Debt / equity as of 2026-07-23 | 1.79 | 6.58 | IART lower |
| Revenue growth (YoY) as of 2026-07-23 | +1.2% | -10.8% | IART higher |
| Revenue CAGR (3y) SEC XBRL | +1.6% | +31.0% | SMTI higher |
| Beta as of 2026-07-23 | 1.21 | 1.19 | |
| 1-year return as of 2026-07-22 close | +67.2% | -3.0% | IART higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.